TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T08519 XX ID T08519 XX DT 01.02.2006 (created); ili. DT 11.02.2015 (updated); spk. CO Copyright (C), QIAGEN. XX FA C2TA-isoform1 XX SY C2TA; Class II TransActivator. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G002341 CIITA; HGNC: CIITA. XX SZ 1130 AA; 123.4 kDa (cDNA) (calc.). XX SQ MRCLAPRPAGSYLSEPQGSSQCATMELGPLEGGYLELLNSDADPLCLYHFYDQMDLAGEE SQ EIELYSEPDTDTINCDQFSRLLCDMEGDEETREAYANIAELDQYVFQDSQLEGLSKDIFK SQ HIGPDEVIGESMEMPAEVGQKSQKRPFPEELPADLKHWKPAEPPTVVTGSLLVGPVSDCS SQ TLPCLPLPALFNQEPASGQMRLEKTDQIPMPFSSSSLSCLNLPEGPIQFVPTISTLPHGL SQ WQISEAGTGVSSIFIYHGEVPQASQVPPPSGFTVHGLPTSPDRPGSTSPFAPSATDLPSM SQ PEPALTSRANMTEHKTSPTQCPAAGEVSNKLPKWPEPVEQFYRSLQDTYGAEPAGPDGIL SQ VEVDLVQARLERSSSKSLERELATPDWAERQLAQGGLAEVLLAAKEHRRPRETRVIAVLG SQ KAGQGKSYWAGAVSRAWACGRLPQYDFVFSVPCHCLNRPGDAYGLQDLLFSLGPQPLVAA SQ DEVFSHILKRPDRVLLILDAFEELEAQDGFLHSTCGPAPAEPCSLRGLLAGLFQKKLLRG SQ CTLLLTARPRGRLVQSLSKADALFELSGFSMEQAQAYVMRYFESSGMTEHQDRALTLLRD SQ RPLLLSHSHSPTLCRAVCQLSEALLELGEDAKLPSTLTGLYVGLLGRAALDSPPGALAEL SQ AKLAWELGRRHQSTLQEDQFPSADVRTWAMAKGLVQHPPRAAESELAFPSFLLQCFLGAL SQ WLALSGEIKDKELPQYLALTPRKKRPYDNWLEGVPRFLAGLIFQPPARCLGALLGPSAAA SQ SVDRKQKVLARYLKRLQPGTLRARQLLELLHCAHEAEEAGIWQHVVQELPGRLSFLGTRL SQ TPPDAHVLGKALEAAGQDFSLDLRSTGICPSGLGSLVGLSCVTRFRAALSDTVALWESLR SQ QHGETKLLQAAEEKFTIEPFKAKSLKDVEDLGKLVQTQRTRSSSEDTAGELPAVRDLKKL SQ EFALGPVSGPQAFPKLVRILTAFSSLQHLDLDALSENKIGDEGVSQLSATFPQLKSLETL SQ NLSQNNITDLGAYKLAEALPSLAASLLRLSLYNNCICDVGAESLARVLPDMVSLRVMDVQ SQ YNKFTAAGAQQLAASLRRCPHVETLAMWTPTIPFSVQEHLQQQDSRISLR XX SC translated from EMBL:U18259 XX FT 1 161 activation domain [2]. FT 51 71 alpha-helix 1, ah1 [2]. FT 84 103 alpha-helix 2, ah2 [2]. FT 124 138 alpha-helix 3, ah3 [2]. FT 163 322 P/S/T domain [3]. FT 200 567 PF00478; IMP dehydrogenase / GMP reductase domain. FT 299 1129 interaction with RFX5 [4]. FT 414 585 PF05729; NACHT domain. FT 414 724 PS50837; NACHT. FT 421 561 homology to the G1, G3, G4 domains of a GTP-binding motif [3]. FT 465 469 leucine charged domain (LCD motif), L1 [1]. FT 525 529 leucine charged domain (LCD motif), L2 [1]. FT 983 1013 SM00368; LRR_RI. FT 995 1079 PS50503; LRR_RI. FT 1014 1041 SM00368; LRR_RI. FT 1016 1039 PF00560; LRR_1. FT 1043 1070 SM00368; LRR_RI. FT 1071 1098 SM00368; LRR_RI. XX IN T04106 HDAC1; human, Homo sapiens. IN T21852 HDAC1; Mammalia. IN T08967 NF-YB; rat, Rattus norvegicus. IN T08521 rfx5-isoform1; human, Homo sapiens. IN T09238 TAFII55; human, Homo sapiens. XX DR TRANSPATH: MO000059554. DR EMBL: U18259; DR UniProtKB: P33076; XX RN [1]; RE0022540. RX PUBMED: 9722631. RA Brown J. A., Rogers E. M., Boss J. M. RT The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element. RL Nucleic Acids Res. 26:4128-4136 (1998). RN [2]; RE0022565. RX PUBMED: 9171108. RA Fontes J. D., Jiang B., Peterlin B. M. RT The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32. RL Nucleic Acids Res. 25:2522-2528 (1997). RN [3]; RE0022567. RX PUBMED: 9122224. RA Chin K. C., Li G. G., Ting J. P-Y. RT Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants. RL Proc. Natl. Acad. Sci. USA 94:2501-2506 (1997). RN [4]; RE0022569. RX PUBMED: 9177217. RA Scholl T., Mahanta S. K., Strominger J. L. RT Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. RL Proc. Natl. Acad. Sci. USA 94:6330-6334 (1997). RN [5]; RE0022578. RX PUBMED: 11003667. RA Hake S. B., Masternak K., Kammerbauer C., Janzen C., Reith W., Steimle V. RT CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. RL Mol. Cell. Biol. 20:7716-7725 (2000). RN [6]; RE0047781. RX PUBMED: 12697811. RA Zika E., Greer S. F., Zhu X. S., Ting J. P. RT Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. RL Mol. Cell. Biol. 23:3091-3102 (2003). XX //